USFDA grants breakthrough device designation to Qure.ai’s AI-powered TB solution
The United States Food and Drug Administration (USFDA) has granted breakthrough device designation to Qure.ai’s AI-powered Tuberculosis (TB) solution, qSpot-TB, a company statement informed. The qSpot-TB Artificial Intelligence (AI) is…